POIA
HAE icon

Pin Oak Investment Advisors’s Haemonetics HAE Stock Holding History

Pin Oak Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3K Hold
42
– – ﹤0.01% 466
2026
Q1 		$2K Hold
42
– – ﹤0.01% 469
2025
Q4 		$2K Sell
42
-65
-61% -$4.37K ﹤0.01% 474
2025
Q3 		$5.21K Buy
+107
New +$6.62K ﹤0.01% 424

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pin Oak Investment Advisors's HAE Position: Q2 2026 in Review

Pin Oak Investment Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 42 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Pin Oak Investment Advisors first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.21K in Q3 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Pin Oak Investment Advisors held 42 shares of Haemonetics worth $3K as of Q2 2026.
  • Pin Oak Investment Advisors left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #466 holding.
  • Pin Oak Investment Advisors first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • Pin Oak Investment Advisors's Haemonetics position peaked at $5.21K in Q3 2025.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.